neurotensin (8-13) has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Accardo, A; Bracci, L; Brunetti, J; Falciani, C; Lelli, B; Morelli, G; Pini, A; Tesauro, D | 1 |
| Blanc, A; Bläuenstein, P; Bruehlmeier, M; Conrath, P; García-Garayoa, E; Iterbeke, K; Schubiger, PA; Tourwé, D | 1 |
2 other study(ies) available for neurotensin (8-13) and Adenocarcinoma
| Article | Year |
|---|---|
Target-selective drug delivery through liposomes labeled with oligobranched neurotensin peptides.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adenocarcinoma; Antineoplastic Agents; Colonic Neoplasms; Drug Delivery Systems; Humans; Hydrodynamics; Liposomes; Lysine; Neurotensin; Peptide Fragments; Rhabdomyosarcoma; Tumor Cells, Cultured | 2011 |
Preclinical evaluation of a new, stabilized neurotensin(8--13) pseudopeptide radiolabeled with (99m)tc.
Topics: Adenocarcinoma; Animals; Female; HT29 Cells; Humans; In Vitro Techniques; Mice; Mice, Nude; Neoplasm Transplantation; Neurotensin; Peptide Fragments; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Neurotensin; Structure-Activity Relationship; Technetium; Tissue Distribution | 2002 |